155 related articles for article (PubMed ID: 21184735)
1. Involvement of HDAC1 in E-cadherin expression in prostate cancer cells; its implication for cell motility and invasion.
Kim NH; Kim SN; Kim YK
Biochem Biophys Res Commun; 2011 Jan; 404(4):915-21. PubMed ID: 21184735
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid inhibits prostate cancer cell migration by up-regulating E-cadherin expression.
Zhang L; Wang G; Wang L; Song C; Wang X; Kang J
Pharmazie; 2011 Aug; 66(8):614-8. PubMed ID: 21901986
[TBL] [Abstract][Full Text] [Related]
3. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer.
Annicotte JS; Iankova I; Miard S; Fritz V; Sarruf D; Abella A; Berthe ML; Noël D; Pillon A; Iborra F; Dubus P; Maudelonde T; Culine S; Fajas L
Mol Cell Biol; 2006 Oct; 26(20):7561-74. PubMed ID: 17015477
[TBL] [Abstract][Full Text] [Related]
5. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ
Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431
[TBL] [Abstract][Full Text] [Related]
6. Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells.
Huang H; Reed CP; Zhang JS; Shridhar V; Wang L; Smith DI
Cancer Res; 1999 Jun; 59(12):2981-8. PubMed ID: 10383164
[TBL] [Abstract][Full Text] [Related]
7. Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin.
Li X; Yin S; Meng Y; Sakr W; Sheng S
Cancer Res; 2006 Sep; 66(18):9323-9. PubMed ID: 16982778
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells.
Chen CL; Sung J; Cohen M; Chowdhury WH; Sachs MD; Li Y; Lakshmanan Y; Yung BY; Lupold SE; Rodriguez R
J Pharmacol Exp Ther; 2006 Nov; 319(2):533-42. PubMed ID: 16868035
[TBL] [Abstract][Full Text] [Related]
9. Involvement of p21waf1/cip1 expression in the cytotoxicity of the potent histone deacetylase inhibitor spiruchostatin B towards susceptible NALM-6 human B cell leukemia cells.
Kanno S; Maeda N; Tomizawa A; Yomogida S; Katoh T; Ishikawa M
Int J Oncol; 2012 May; 40(5):1391-6. PubMed ID: 22211246
[TBL] [Abstract][Full Text] [Related]
10. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
Lin YC; Lin JH; Chou CW; Chang YF; Yeh SH; Chen CC
Cancer Res; 2008 Apr; 68(7):2375-83. PubMed ID: 18381445
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells.
Catalano MG; Fortunati N; Pugliese M; Marano F; Ortoleva L; Poli R; Asioli S; Bandino A; Palestini N; Grange C; Bussolati B; Boccuzzi G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1150-9. PubMed ID: 22563106
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition and gene induction in human hepatocellular carcinoma cell exposed to sodium 4-phenylbutanoate.
Wang CT; Meng M; Zhang JC; Jin CJ; Jiang JJ; Ren HS; Jiang JM; Qin CY; Yu DQ
Chin Med J (Engl); 2008 Sep; 121(17):1707-11. PubMed ID: 19024104
[TBL] [Abstract][Full Text] [Related]
13. A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression.
Chu Q; Ling MT; Feng H; Cheung HW; Tsao SW; Wang X; Wong YC
Carcinogenesis; 2006 Nov; 27(11):2180-9. PubMed ID: 16675472
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of curcumin on histone deacetylase and expression promotion of P21 (WAF1/CIP1) in HepG2 cells].
Lv BH; Zhang L; Zhu CC; Liu J
Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2051-5. PubMed ID: 18161303
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
Frønsdal K; Saatcioglu F
Prostate; 2005 Feb; 62(3):299-306. PubMed ID: 15389787
[TBL] [Abstract][Full Text] [Related]
16. Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion.
Hudak L; Tezeeh P; Wedel S; Makarević J; Juengel E; Tsaur I; Bartsch G; Wiesner C; Haferkamp A; Blaheta RA
Prostate; 2012 Dec; 72(16):1719-35. PubMed ID: 22473339
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer.
Jaggi M; Rao PS; Smith DJ; Wheelock MJ; Johnson KR; Hemstreet GP; Balaji KC
Cancer Res; 2005 Jan; 65(2):483-92. PubMed ID: 15695390
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models.
Qian DZ; Wei YF; Wang X; Kato Y; Cheng L; Pili R
Prostate; 2007 Aug; 67(11):1182-93. PubMed ID: 17520666
[TBL] [Abstract][Full Text] [Related]
19. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor.
Kim DH; Lee J; Kim KN; Kim HJ; Jeung HC; Chung HC; Kwon HJ
Biochem Biophys Res Commun; 2007 Apr; 356(1):233-8. PubMed ID: 17353008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
